To determine if the imatinib-insensitive p185 KO2.3 IMr cells and p185 KO 6.2 IMr cells regain the leukemogenic activity in vivo, we injected these cells into mice and monitored leukemia development. The gene discussed is EIF3A; the disease is leukemia.